Epeius Tumor-targeted Gene Delivery Gains in Medicine and Patent Protection
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for another crucial patent covering its leading tumor-targeted gene delivery platform. The issuance of this high-value patent protection for targeting metastatic disease follows on the heels of two major patent issuances.
Minnesota Medical Development among Top 50 Companies to Watch on annual list
MINNEAPOLIS, Minn. -- Minnesota Medical Development, Inc. (MMDI) today announced that it has been named as one of the 'Top 50 Companies to Watch' in the medical device industry by Medical Device and Diagnostic Industry (MD+DI) magazine. MMDI was chosen because of its ability to achieve success and also for its ability to manufacture products that have the potential to revolutionize care practices.
Illinois' Affinity Healthcare LLC Adds Neurology Specialty
BUFFALO GROVE, Ill. -- Affinity Healthcare LLC, a multi-specialty medical group practice with northwest Chicago suburban offices located in Arlington Heights and Buffalo Grove announces the addition of a Neurology specialist to its cadre of 34 physicians. Dr. Daniel B. Cacioppo, MD will treat patients by appointment at the Affinity Healthcare LLC office located at 1450 Busch Parkway, Buffalo Grove, IL 60089.
ASCO 2010: Studies of Targeted Gene Delivery Confirm That Rexin-G Impacts Survival in Chemotherapy-resistant Bone and Soft Tissue Sarcoma
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announces the results of the clinical trial entitled 'Advanced Phase I/II Evaluation of Tumor-Targeted Gene Delivery: Intravenous Rexin-G as Stand Alone Therapy for Chemotherapy-resistant Bone and Soft Tissue Sarcoma' at the ASCO Annual Meeting on June 8, 2010. The presentation will be discussed by Dr. Kristen N. Ganjoo, Stanford University Medical Center, Palo Alto CA.
ASCO 2010: Epeius Tumor-targeted Rexin-G Prolongs Survival in Gemcitabine-resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announces the results of the clinical study entitled 'Phase I and II Studies of Intravenous Rexin-G as Monotherapy for Gemcitabine-resistant Metastatic Pancreas Cancer' at the ASCO Annual Meeting on June 6, 2010. The presentation will be discussed by Dr. Howard W. Bruckner, Bruckner Oncology, New York, NY.
Epeius Tumor-Targeted Nanoparticle-based Gene Delivery Provides Evidence of Therapeutic Vaccination in Patients with Metastatic Cancer
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announces the clinical results of the study entitled 'A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol' at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Web-based Home Care Software from ContinuLink Now Integrates with Cardiocom
ATLANTA, Ga. -- ContinuLink, a leader in Web-based home care software has announced that it has entered into a business development relationship with Cardiocom to provide a two way interface between Cardiocom's Omnivisor Pro software application and the Web-based ContinuLink application. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.
Plant and Send Customized e-cards from Virtual Flower Garden for Mother's Day 2010
SUNRISE, Fla. -- This Mother's Day, Interim HealthCare Inc., the nation's largest and oldest franchise healthcare company, is recognizing moms across the country with unique Mother's Day e-cards. The e-cards allow users to share their favorite stories about their mothers and create a customized flower in her honor.
Expert Reviews of Epeius Bio's Targeted Genetic Medicine for Metastatic Cancer
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation, a leader in the field of targeted genetic medicine, reports the publication of three major publications in the field. The first article entitled 'Rexin-G, A Targeted Genetic Medicine for Metastatic Cancer' (Expert Opinion on Biological Therapy, May, 2010) documents the development of Rexin-G: a tumor-targeted retrovector bearing a cytocidal cyclin G1 construct; the first targeted gene therapy vector to gain FDA Fast Track designation and Orphan Drug priorities for multiple cancer indications in the USA.
Mother's Day 2010 Donations Part of the Sher Institute Giving Back Program
LAS VEGAS, Nev. -- Sher Institute for Reproductive Medicine (SIRM) is donating free In-Vitro Fertilization (IVF) treatments at upcoming fertility education seminars on May 11 and 12, in celebration of Mother's Day on May 9, 2010. The donated treatment cycles are part of the Sher Institute 'Giving Back' Program.
Topcon Medical Systems EyeRoute Imaging Software Now Available for iPhone and iPad
PARAMUS, N.J. -- Topcon Medical Systems announced today that the mobile version of its successful EyeRoute(R) Image Management Suite is now available as a dedicated iPhone application from the Apple(R) iTunes store in North America. First presented in October 2009 at the American Academy of Ophthalmology Meeting in San Francisco, EyeRoute Mobile sets the stage for connectivity on the go.
Eularis Updated Reports Help Pharma Companies Do More for Real Growth
LONDON, U.K. -- The pharmaceutical industry is facing unprecedented challenges on many fronts - a slew of patient expiries, a lack of blockbusters in the pipeline to replace the patent expiries, decreasing growth in many major markets, generic competition, constantly changing regulatory and competitive environment rendering old tools for analysis obsolete, increased pressure on CEOs to deliver shareholder growth resulting in budget cuts, downsizing, and less than optimal results.
World TB Day: Breathe California Announces State-Wide Media Call on Tuberculosis
SAN JOSE, Calif. -- Tuberculosis (TB) is still a global and local threat. Hear the latest global, U.S., California, and local trends in TB, and recommendations from the experts. Breathe California is hosting a state-wide Media Call on Tuberculosis on Tuesday, March 23, 10:30 a.m. PDT. March 24th is World TB Day.
Marty Niedelman: Theory on Cancer Cure – Fact or Fiction
NEW YORK, N.Y. -- Marty Niedelman (www.martivation.com), a pharmacist from New York, claims he has the answer which will lead to the cure of...
Epeius Bio's Rexin-G® Receives High-tech Validation as Strategic Anti-cancer Agent
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science...
First 'Viagra baby' conceived through IVF using Sildenafil on a woman to aid in embryo implantation will turn 10 next month
NEW ORLEANS, La. -- The Sher Institute for Reproductive Medicine announced that the first baby conceived through IVF using Sildenafil (Viagra(R)) on a woman...
Dr. Sid Kamali joins Renaissance Surgical Arts at Newport Harbor
COSTA MESA, Calif. -- Renaissance Surgical Arts at Newport Harbor, a new multi-specialty outpatient surgery center committed to setting a new standard of care...
Epeius Biotech Reports Dose-Dependent Efficacy and Survival Benefits, Efficacy of Rexin-G in Metastatic Pancreas Cancer
SAN MARINO, Calif. -- Epeius Biotechnologies (www.epeiusbiotech.com) confirms the first real breakthrough for pancreatic cancer seen in years; publishes a landmark report of tumor-targeted...
Tumor-targeted REXIN-G Quells Metastatic Osteosarcoma, Prostate Cancer, and Pancreas Cancer as Stand-alone Therapy
SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so...
New York's CityMade Logistics to Distribute Celox Blood Clotting Products
BUFFALO, N.Y. -- U.K. Medical products manufacturer MedTrade Products Ltd. has selected CityMade Logistics to manage the sales, marketing and distribution of Celox(TM) blood...
Christine Joseph, RN, joins Renaissance Surgical Arts at Newport Harbor
COSTA MESA, Calif. -- Renaissance Surgical Arts at Newport Harbor, a new multi-specialty outpatient surgery center committed to advancing surgical technologies and patient care...
Illinois' Affinity Healthcare LLC Announces New Physicians
BUFFALO GROVE, Ill. -- Affinity Healthcare LLC, a multi-specialty medical group practice with northwest Chicago suburban offices located in Arlington Heights and Buffalo Grove,...
Renaissance Surgical Arts at Newport Harbor adds Michael Sundine MD to Board
COSTA MESA, Calif. -- Renaissance Surgical Arts at Newport Harbor, a new cutting edge outpatient surgical facility located within the Pacific Medical Plaza building...
Long Island fertility doctor declares an end to high order multiples with groundbreaking financial subsidy for single embryo transfers
PLAINVIEW, N.Y. -- Dr. David Kreiner, a nationally renowned Long Island reproductive specialist, takes on the long-standing moral and medical dilemma of multiples with...
Lifemodeler Targets Lower Back Pain with New Software
SAN CLEMENTE, Calif. -- LifeModeler, Inc., the leading global provider of biomechanical human body simulation tools and services, has released LumbarSIM(TM), a new product...


